Cidara Therapeutics (CDTX) had the highest return in 2015 by a US stock with a market cap of $100M+, returning 2,045%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Cidara Therapeutics (CDTX) | 2015 | 2,045% |
FingerMotion (FNGR) | 2015 | 940% |
Patriot National Bancorp (PNBK) | 2015 | 798.18% |
MDxHealth SA ADR (MDXH) | 2015 | 633.33% |
Anavex Life Sciences (AVXL) | 2015 | 632.89% |
Theratechnologies (THTX) | 2015 | 335.48% |
Celsius (CELH) | 2015 | 287.94% |
Exelixis (EXEL) | 2015 | 283.67% |
Galapagos NV ADR (GLPG) | 2015 | 231.72% |
Prothena (PRTA) | 2015 | 224.33% |
LightPath Technologies (LPTH) | 2015 | 211.23% |
eXp World (EXPI) | 2015 | 184.69% |
Sarepta Therapeutics (SRPT) | 2015 | 164.61% |
Heron Therapeuti (HRTX) | 2015 | 162.28% |
Caesars Entertainment (CZR) | 2015 | 159.43% |
Ultragenyx (RARE) | 2015 | 152.54% |
Neurocrine Biosciences (NBIX) | 2015 | 150.42% |
Globant (GLOB) | 2015 | 142.78% |
Wayfair (W) | 2015 | 138.22% |
LeMaitre Vascular (LMAT) | 2015 | 137.18% |
Netflix (NFLX) | 2015 | 132.71% |
Smith & Wesson Brands (SWBI) | 2015 | 130.16% |
Collegium Pharmaceutical (COLL) | 2015 | 129.17% |
Aclaris Therapeutics (ACRS) | 2015 | 125.63% |
Genmab A-S (GMAB) | 2015 | 123.37% |
